Lacosamide Injection
Product Images NDC 60505-6235

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 60505-6235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel.jpg (Cartonlabel)

Cartonlabel.jpg (Cartonlabel)
The text is not readable.*
FDA Label Image

Figure1.jpg (Figure1)

Figure1.jpg (Figure1)
Study 3 shows a statistically significant difference of 35 compared to the placebo group.*
FDA Label Image

Figure2.jpg (Figure2)

Figure2.jpg (Figure2)
This information displays data related to responder rates for different dosages of lacosamide, a medication being evaluated potentially for efficacy in improving a particular condition. The data includes the number of participants in each group and the doses they are receiving (200mg/day, 400mg/day, and 600mg/day). It also mentions improvement and worsening in relation to the treatment.*
FDA Label Image

Structure.jpg (Structure)

FDA Label Image

Viallabel.jpg (Viallabel)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.